論文・技術情報追加のお知らせ

1. An Exploratory Research to Evaluate the 30 Most Common Pulmonary Embolism Drugs in the Food and Drug Administration Adverse Event Reporting System.

肺塞栓症と関連する一般薬剤の評価

対象DB：FAERS

2. A real-world disproportionality analysis of Tenofovir Alafenamide (TAF): Data mining of the FDA adverse event reporting system (FAERS).

TAF治療の安全性評価と新たなリスク発見

対象DB：FAERS

3. An Evaluation of Duplicate Adverse Event Reports Characteristics in the Food and Drug Administration Adverse Event Reporting System.

FAERSの重複報告特性を分析

対象DB：FAERS

4. Immune-mediated enterocolitis is associated with immune checkpoint inhibitors: A pharmacovigilance study from the FDA Adverse Event Reporting System (FAERS) database.

ICI治療における腸炎リスク評価

対象DB：FAERS

5. A disproportionality analysis of nervous system adverse events associated with disease-modifying therapies in multiple sclerosis: insights from the FDA adverse event reporting system (FAERS).

DMTの神経系副作用リスクを評価

対象DB：FAERS

6. Comparative disproportionality analysis of adverse events associated with combined therapy versus monotherapy of abiraterone and olaparib for prostate cancer: a pharmacovigilance study using the FAERS database.

アビラテロンとオラパリブの合併療法のリスク

対象DB：FAERS

7. Post-marketing safety surveillance of voclosporin: an observational, pharmacovigilance study leveraging faers database study on the safety of voclosporin.

ボクロスポリンの安全性特性を評価

対象DB：FAERS

8. Risk Assessment of Linezolid-Associated Neurological Adverse Drug Reactions Based on the Food and Drug Administration Adverse Event Reporting System Database.

リネゾリドの神経系副作用の分析

対象DB：FAERS

9. Adverse cardiac events associated with antibody drug conjugates in cancer patients: a retrospective analysis on the FAERS database and randomized controlled trials.

がん患者における抗体薬物複合体の心毒性評価

対象DB：FAERS

10. Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database.

ビスモデギブの安全性プロファイル評価

対象DB：FAERS

11. Stroke and Thrombotic Events Associated With Concomitant Use of Oral Anticoagulants and Antiepileptic Drugs in the United States and Japan.

直接経口抗凝固薬と抗てんかん薬併用のリスクを評価

対象DB：FAERS,JADER

12. Safety Profile of Lithium: A Disproportionality Analysis Using the FDA Adverse Event Reporting System.

リチウム治療の安全性プロファイルの総合的評価

対象DB：FAERS

13. Adverse events associated with four atypical antipsychotics used as augmentation treatment for major depressive disorder: A pharmacovigilance study based on the FAERS database.

抗精神病薬での大うつ病障害治療の副作用

対象DB：FAERS

14. Immunotherapy-induced cholestasis in cancer: insights from the two real-world pharmacovigilance databases of FAERS and vigiBase.

免疫チェックポイント阻害薬による肝障害のリスク

対象DB：VigiBase

15. Influence of patient age and sex on drug-induced liver injury caused by antiseizure medications: a disproportionality analysis of VigiBase.

抗てんかん薬の肝障害リスク、年齢性別影響

対象DB：VigiBase

16. Impact of the Japanese clinical practice guidelines for management of sepsis and septic shock (J-SSCG) 2020 on real-world adherence and interhospital variation: a nationwide inpatient database study.

ガイドライン実施後の敗血症ケアの遵守率にわずかな改善

対象DB：DPC

17. Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study.

SARS-CoV-2感染と心血管疾患のリスクの関連を調査

対象DB：JMDC

18. Depression and its association with mortality in idiopathic pulmonary fibrosis: A real-world data analysis.

特発性肺線維症患者のうつ病とその影響を調査

対象DB：NDB

19. A prediction model for diabetes complications using the Kokuho Database and its application to public health services in Japan.

日本の健康指導プログラムの効率性向上を目指す

対象DB：NDB

20. Vancomycin-associated acute kidney injury and its clinical and economic impact: a retrospective cohort study using two Japanese healthcare databases.

バンコマイシン関連の急性腎障害の影響を分析

対象DB：MDV

21. The impact of potentially inappropriate medicines on adverse clinical outcomes in the aged: A retrospective cohort study.

適切でない薬が入院や転倒、薬の副作用に関連

対象DB：CPRD

22. Trends in the prevalence of autoimmune diseases during pregnancy in the UK, 2000-21: a retrospective cohort study.

自己免疫疾患の妊娠中の負担と影響を調査

対象DB：CPRD

23. Prevalence and incidence of moderate and severe mental illness in the second postpartum year in England (1995-2020): a national retrospective cohort study using primary care data.

産後２年間の精神病の発生率と重症度

対象DB：CPRD

24. Inflammatory diseases and risk of lung cancer among individuals who have never smoked.

喫煙歴のない肺がんと関連する病気を特定

対象DB：CPRD

25. Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data.

糖尿病第二選択薬の効果を比較分析

対象DB：CPRD

26. First opinion practice electronic health records are a useful source of descriptions of medication errors.

獣医療の電子カルテから処方ミスを特定

対象DB：CVAR

27. Factors associated with severe lower extremity artery disease in type 2 diabetes based on a large scale claims database in Japan.

糖尿病性下肢動脈疾患の進行抑制要因を調査

対象DB：DeSC

28. Current Epidemiological and Clinical Features of Sarcoidosis in Japan: A Nationwide Claims Data Study.

日本のサルコイドーシスの疫学データ分析

対象DB：DeSC